Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies. <p></p> Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. <p></p> Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap. <p></p>.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Current pharmacogenomics and personalized medicine - 15(2017), 1, Seite 60-66 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Finelli, Rosa [VerfasserIn] |
---|
Links: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC2000014933 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2000014933 | ||
003 | DE-627 | ||
005 | 20240324142315.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180127s2017 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a Paket_Artikel_Pharmazie_20180125.pp |
035 | |a (DE-627)OLC2000014933 | ||
035 | |a (DE-599)GBVOLC2000014933 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 15,3 |2 ssgn | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Finelli, Rosa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tackling Cardiovascular Risk: New Evidence from Personalized Medicine |
264 | 1 | |c 2017 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies. <p></p> Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. <p></p> Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap. <p></p> | ||
700 | 1 | |a Pascale, Antonietta V. |e verfasserin |4 aut | |
700 | 1 | |a Marotta, Paola |e verfasserin |4 aut | |
700 | 1 | |a Guida, Anna |e verfasserin |4 aut | |
700 | 1 | |a Ciccarelli, Michele |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current pharmacogenomics and personalized medicine |d Sharjah : Bentham, 2008 |g 15(2017), 1, Seite 60-66 |h Online-Ressource |w (DE-627)565517295 |w (DE-600)2424232-9 |w (DE-576)30683636X |x 1875-6913 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2017 |g number:1 |g pages:60-66 |
856 | 4 | 0 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1875-6921&volume=15&issue=1&spage=60 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-DE-84 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_1200 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
951 | |a AR | ||
952 | |d 15 |j 2017 |e 1 |h 60-66 |